Navigation Links
Arrowhead Subsidiary Calando Pharmaceuticals Publishes Study,Showing Anti-Cancer Effect with Lead RNAi Candidate

jority owned subsidiaries founded on nanotechnologies originally developed at universities. The company works closely with universities to source early stage deals and to generate rights to intellectual property covering promising new nanotechnologies. Currently, Arrowhead has four subsidiaries commercializing nanotech products and applications, including anti-cancer drugs, RNAi therapeutics, carbon-based electronics and compound semiconductor materials.

About Calando Pharmaceuticals Inc.

Calando Pharmaceuticals Inc. (www.calandopharma.com), a majority owned subsidiary of Arrowhead Research Corporation (NASDAQ: ARWR), is using its proprietary technologies in targeted polymeric delivery systems and siRNA design to design and create new, targeted siRNA therapeutics. The company is pursuing this goal through its internal research and development and also through collaborations and partnerships with pharmaceutical and biotechnology companies.

Calando Technology

Calando's cyclodextrin-containing polymers form the foundation for its two-part siRNA delivery system. The first component is a linear, cyclodextrin-containing polycation that, when mixed with small interfering RNA (siRNA), binds to the anionic "backbone" of the siRNA. The polymer and siRNA self-assemble into nanoparticles of approximately 50-80 nm in diameter that fully protect the siRNA from nuclease degradation in serum. The siRNA delivery system has been designed to allow for intravenous injection. Upon delivery to the target cell, the targeting ligand binds to membrane receptors on the cell surface and the RNA-containing nanoparticle is taken into the cell by endocytosis. There, chemistry built into the polymer functions to unpackage the siRNA from the delivery vehicle. In addition to targeting tumors, the targeting of liver cells has also been accomplished in vivo.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995:

This news release co
'"/>




Page: 1 2 3

Related medicine technology :

1. Arrowhead Subsidiary, Insert, Publishes Interim Phase I Data from Human Clinical Trials for New Cancer Drug
2. Arrowhead Subsidiaries Insert & Calando Present Data on Cyclosert Drug Delivery System at AACR Meeting
3. Arrowhead Subsidiary, Calando Pharmaceuticals Publishes Study on Targeted, Systemic Delivery of siRNA
4. CytRx Announces RNAi Delivery Nanoparticle Technology Exclusively Licensed to Subsidiary, RXi Pharmaceuticals, Described in Peer-Reviewed Journal
5. Calando Pharmaceuticals Announces Preclinical Efficacy and Safety Data of Targeted, Systemic Delivery of siRNA at AACR Annual Meeting
6. Calando Pharmaceuticals Publishes Study Showing Anti-Cancer Effect with Lead RNAi Candidate
7. Calando Pharmaceuticals Publishes the First Non-Human Primate Study on Targeted, Systemic Delivery of siRNA in National Academy of Sciences Journal
8. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
9. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
10. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
11. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
Post Your Comments:
(Date:3/26/2015)... Md. , March 26, 2015  RegeneRx Biopharmaceuticals, ... it has received a patent acceptance notice from the ... 4 (TB4) to prevent or reduce tissue damage caused ... the case when cardiac vessels are opened after a ... when treating stroke victims. Damage can be ...
(Date:3/26/2015)... , March 26, 2015  Becton, Dickinson and ... it will commence offers to exchange all validly tendered ... CareFusion Corporation, a wholly owned subsidiary of BD, for ... the table below. A Registration Statement on Form S-4 ... New Notes was filed with the Securities and Exchange ...
(Date:3/26/2015)... , March 26, 2015 IGI Laboratories, Inc. ... based specialty generic pharmaceutical company, today announced it ... to the U.S. Food and Drug Administration (FDA) of ... submissions now pending at the FDA to twenty-three. ... the Company, commented, "On March 2, 2015, we committed ...
Breaking Medicine Technology:RegeneRx Receives Israeli Patent Acceptance Notice for the Use of TB4 To Prevent Tissue Damage Associated with Heart Attack and Stroke Treatments 2RegeneRx Receives Israeli Patent Acceptance Notice for the Use of TB4 To Prevent Tissue Damage Associated with Heart Attack and Stroke Treatments 3Becton, Dickinson and Company to Commence Exchange Offers 2Becton, Dickinson and Company to Commence Exchange Offers 3Becton, Dickinson and Company to Commence Exchange Offers 4Becton, Dickinson and Company to Commence Exchange Offers 5IGI Laboratories, Inc. Announces First ANDA Submission Of 2015 2
... Higher ... to Standard Chemotherapy, SEATTLE, Nov. 11 Cell Therapeutics, ... the primary,efficacy endpoint of its phase III EXTEND (PIX301) trial ... based on a preliminary intent to treat efficacy analysis.,Patients randomized ...
... Pharmasset, Inc.,(Nasdaq: VRUS ), Roche (SWX: ROG) and ... first patients have been dosed in an innovative clinical,trial ... (HCV).,The trial (run in centers in Australia and New ... oral antiviral molecules in the absence,of interferon., The ...
Cached Medicine Technology:Cell Therapeutics' Pixantrone Phase III (EXTEND) Pivotal Trial Successful in Achieving Primary Endpoint 2Cell Therapeutics' Pixantrone Phase III (EXTEND) Pivotal Trial Successful in Achieving Primary Endpoint 3Cell Therapeutics' Pixantrone Phase III (EXTEND) Pivotal Trial Successful in Achieving Primary Endpoint 4Roche, InterMune and Pharmasset Announce Initiation of INFORM-1, the First Dual-Combination Clinical Trial with Oral Antivirals in Hepatitis C 2Roche, InterMune and Pharmasset Announce Initiation of INFORM-1, the First Dual-Combination Clinical Trial with Oral Antivirals in Hepatitis C 3Roche, InterMune and Pharmasset Announce Initiation of INFORM-1, the First Dual-Combination Clinical Trial with Oral Antivirals in Hepatitis C 4Roche, InterMune and Pharmasset Announce Initiation of INFORM-1, the First Dual-Combination Clinical Trial with Oral Antivirals in Hepatitis C 5
(Date:3/26/2015)... San Francisco, CA (PRWEB) March 26, 2015 ... webinars. These will be on the topics of the DAOM ... , The DAOM Program Overview Webinar will be hosted by ... program and provide the next steps on how to prepare ... to 12:30 p.m. March 25, March 27, April 1 and ...
(Date:3/26/2015)... New York (PRWEB) March 26, 2015 ... to move forward nationwide, with the issuance of ... in Pennsylvania and Louisiana. According to an Order ... multidistrict litigation established for Xarelto injury claims in ... will now allow plaintiffs to file cases directly ...
(Date:3/26/2015)... 26, 2015 Behavioral Research Group, ... announced the release of BathroomMap® , a new ... access to public restrooms for travelers, especially those with ... BathroomMap does not facilitate a paid, social or crowdsourced ... and rate local establishments that have clean, available restrooms ...
(Date:3/26/2015)... 26, 2015 Saving Moses is a ... is most needed but least available. As one of ... six clinics in the Benguela province of Angola to ... a recent visit to their clinics, staff employed the ... and their babies in a nation the The New ...
(Date:3/26/2015)... March 26, 2015 The Life ... “Introduction to Hyperbaric Medicine” course, which is accredited ... (UHMS) and the National Board of Diving & ... 40-hour course 4 times a year at several ... NY tri-state region; registration is available on-line at: ...
Breaking Medicine News(10 mins):Health News:ACTCM Announces Upcoming Webinars 2Health News:Xarelto Lawsuits Move Forward Nationwide, With Issuance of New Court Docs in State, Federal Litigations 2Health News:Xarelto Lawsuits Move Forward Nationwide, With Issuance of New Court Docs in State, Federal Litigations 3Health News:New Bathroom Finder App, BathroomMap®, Helps People with Medical Needs Who Urgently Need a Bathroom When Traveling 2Health News:New Bathroom Finder App, BathroomMap®, Helps People with Medical Needs Who Urgently Need a Bathroom When Traveling 3Health News:Saving Moses Utilized Photography in an Effort to Engage Mothers and Their Babies on a Recent Visit to Angola 2Health News:The Life Support Technologies Group (LST) Conducted its 30th Accredited “Introduction to Hyperbaric Medicine” Course for Health Care Professionals 2Health News:The Life Support Technologies Group (LST) Conducted its 30th Accredited “Introduction to Hyperbaric Medicine” Course for Health Care Professionals 3Health News:The Life Support Technologies Group (LST) Conducted its 30th Accredited “Introduction to Hyperbaric Medicine” Course for Health Care Professionals 4
... in Nine Infants, Especially in ... Premature and Minority Babies, ST. LOUIS, Oct. ... overall need for concern, according to new data,collected by the American ... The overall need,for concern has increased from one in 14 last ...
... Opportunities, LAS VEGAS, Oct. 26 As ... product pipeline and pharmaceutical contacts,Skinvisible, Inc. (OTC Bulletin ... a patented polymer delivery system for,topical skincare products, ... to its Advisory Board. Dr. Korkos is a ...
... in Animal Disaster,Assistance Offer Advice for Evacuees, Others, ... United Animal,Nations (UAN), the organization that pioneered ... emergency animal sheltering and disaster relief,services during Hurricane ... 2003, is offering financial assistance grants of up ...
... effort to raise,awareness about health plan quality, the Oct. ... feature a cover story entitled "America,s Best Health,Plans 2007." ... 50 commercial,health plans, as well as the top 25 ... the rankings are based upon data from the National,Committee ...
... State licenses MediMAR for 11 Behavioral Health ... Increasing its market,presence in behavioral health medication ... ) announced today that the Texas Department ... to license additional,components of Mediware,s ClosedLoop(TM) Medication ...
... 300 jobs, PITTSBURGH, Oct. 26 The ... Highmark Medicare Services Inc. as the new,Medicare Administrative ... Part B fee-for-service claims and other administrative activities ... Medicare Services will,process Medicare fee-for-services claims from hospitals ...
Cached Medicine News:Health News:2007 InfantSEE(R) Data Magnifies the Need for Early Eye and Vision Screenings for Infants, According to American Optometric Association 2Health News:2007 InfantSEE(R) Data Magnifies the Need for Early Eye and Vision Screenings for Infants, According to American Optometric Association 3Health News:Skinvisible Appoints Dr. George Korkos to Its Advisory Board 2Health News:Skinvisible Appoints Dr. George Korkos to Its Advisory Board 3Health News:United Animal Nations Offers Financial Assistance Grants of up to $500 to Help Southern California Fire Victims Obtain Vet Care, Temporary Boarding for Pets 2Health News:United Animal Nations Offers Financial Assistance Grants of up to $500 to Help Southern California Fire Victims Obtain Vet Care, Temporary Boarding for Pets 3Health News:United Animal Nations Offers Financial Assistance Grants of up to $500 to Help Southern California Fire Victims Obtain Vet Care, Temporary Boarding for Pets 4Health News:Blue Cross and Blue Shield of Florida NCQA/U.S. News & World Report Ranking 2Health News:Texas Health and Human Services Commission Adopts Mediware's ClosedLoop(TM) Medication Management Strategy 2Health News:Texas Health and Human Services Commission Adopts Mediware's ClosedLoop(TM) Medication Management Strategy 3Health News:Highmark Medicare Services Awarded New Contract from Centers for Medicare & Medicaid Services 2
... to Z Drug Facts produced by ... on thousands of medications. It provides ... effect, drug interactions, patient information and ... reference for physicians, students, residents, pharmacists, ...
Very concise book answering the question: "I've got a diagnosis, which drugs do I use?". All 15 chapters written by highly skilled US specialists...
... with Integrated Calculators, based on Davis's Drug ... advance in drug reference. DDGNIC contains the ... Guide (9th Edition) and has integrated calculation ... product merges many of the advantages of ...
Allows health professionals to answer consumers' questions regarding safety issues concerning possible drug-herb and drug-food interactions....
Medicine Products: